Investigation of in-vitro Efficacy of Antibiotic Combinations and Presence of Carbapenemases in Multidrug-Resistant Klebsiella pneumoniae Isolates
| dc.contributor.author | Aksoy, Pelin Kamuran Duran | |
| dc.contributor.author | Caliskan, Emel | |
| dc.date.accessioned | 2026-07-01T11:39:14Z | |
| dc.date.available | 2026-07-01T11:39:14Z | |
| dc.date.issued | 2026 | |
| dc.department | Düzce Üniversitesi | |
| dc.description.abstract | Background: Multidrug resistance (MDR) is increasingly being detected in Klebsiella pneumoniae strains. The combined use of antibiotics is one of the important choices in the treatment of these infections. Objectives: This study aimed to evaluate the in vitro activity of the binary combinations of colistin (COL), meropenem (MEM), and ceftazidime/avibactam (CZA) against multidrug-resistant K pneumoniae clinical isolates and to identify carbapenemase genes. Methods: Between January 2022 and November 2023, randomly selected MDR K. pneumoniae isolates (n = 90) isolated from patient samples were included in the study. All isolates were investigated for carbapenem resistance genes using the PCR method. Additionally, the carbapenem inactivation method (CIM) was used as a phenotypic method to investigate carbapenemase production. Antimicrobial interactions (synergy test) were determined using the checkerboard method. Results: The most common carbapenem resistance gene was OXA-48 (72 isolates). The KPC gene was detected in 10 isolates, and the NDM gene in 5 isolates. A synergy test was performed on isolates randomly selected from among those resistant to at least one of the antibiotics COL, CZA, and MEM. Synergistic effect was detected in 50% of the COL-CZA combination, 75% of the MEM-CZA combination, and 45% of the MEM-COL combination. Conclusions: OXA-48 was the most frequently detected carbapenemase gene in MDR K pneumoniae isolates in our region, and KPC and NDM carbapenemase genes were also detected. The high synergy-partial synergy ratios identified in antibiotics may represent a promising treatment option for infections caused by MDR K pneumoniae, but this requires confirmation in studies with larger sample sizes. | |
| dc.identifier.doi | 10.5812/jjm-169256 | |
| dc.identifier.issn | 2008-3645 | |
| dc.identifier.issn | 2008-4161 | |
| dc.identifier.issue | 2 | |
| dc.identifier.orcid | 0000-0002-7838-2067 | |
| dc.identifier.uri | https://doi.org/10.5812/jjm-169256 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12684/23173 | |
| dc.identifier.volume | 19 | |
| dc.identifier.wos | WOS:001700798700001 | |
| dc.identifier.wosquality | Q4 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.language.iso | en | |
| dc.publisher | Brieflands | |
| dc.relation.ispartof | Jundishapur Journal of Microbiology | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_WOS_20260623 | |
| dc.subject | [Keyword Not Available] | |
| dc.title | Investigation of in-vitro Efficacy of Antibiotic Combinations and Presence of Carbapenemases in Multidrug-Resistant Klebsiella pneumoniae Isolates | |
| dc.type | Article |












